These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7230157)

  • 21. A rare case of systemic autoimmune disease with intricate features of systemic sclerosis, lupus, polymyositis and rheumatoid arthritis. Overlap syndrome or mixed connective tissue disease?
    Radulescu D; Pripon S; Ciovicescu F; Constantea NA
    Acta Reumatol Port; 2007; 32(3):292-7. PubMed ID: 17932479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic workup for mixed connective tissue disease in childhood.
    Swart JF; Wulffraat NM
    Isr Med Assoc J; 2008; 10(8-9):650-2. PubMed ID: 18847172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon.
    Maricq HR; Weinberger AB; LeRoy EC
    J Rheumatol; 1982; 9(2):289-91. PubMed ID: 7097688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Raynaud's disease--Raynaud's syndrome].
    Trübestein G; Sobbe A
    Med Klin; 1974 Nov; 69(48):1990-5. PubMed ID: 4453292
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary hypertension not a major feature of early mixed connective tissue disease: a prospective clinicoserological study.
    Haroon N; Nisha RS; Chandran V; Bharadwaj A
    J Postgrad Med; 2005; 51(2):104-7, discussion 107-8. PubMed ID: 16006700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How to recognize scleroderma].
    Francès C; Ayoub N; Barete S
    Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?
    Kallenberg CG; Wouda AA; The TH
    Neth J Med; 1984; 27(9):322-6. PubMed ID: 6334812
    [No Abstract]   [Full Text] [Related]  

  • 30. The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon.
    Anderson ME; Moore TL; Lunt M; Herrick AL
    Rheumatology (Oxford); 2007 Mar; 46(3):533-8. PubMed ID: 17018538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac involvement in mixed connective tissue disease. A fatal case of scleroderma combined with systemic lupus erythematosus.
    Przybojewski JZ; Mynhardt JH; van der Walt JJ; Tiedt FA
    S Afr Med J; 1985 Oct; 68(9):680-6. PubMed ID: 4060033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
    Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
    Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic connective tissue diseases in India, VI. Raynaud's disease and pre-progressive systemic sclerosis (Pre-PSS).
    Malaviya AN; Narayanan K; Tiwari SC; Khan KM; Raina V; Pande JN
    J Assoc Physicians India; 1983 Oct; 31(10):625-8. PubMed ID: 6671930
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Loss of digital substance in rheumatic diseases. Apropos of 43 cases].
    Huaux JP; Esselinckx W; Meunier H; Dufour JP; Devogelaer JP; Nagant de Deuxchaisnes C
    Rev Rhum Mal Osteoartic; 1987; 54(7-9):549-53. PubMed ID: 3499655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E; Szegedi G
    Orv Hetil; 2002 Feb; 143(5):229-33. PubMed ID: 11875835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphologic study of the microcirculation in connective tissue diseases].
    Cantatore FP; Corrado A; Covelli M; Lapadula G
    Ann Ital Med Int; 2000; 15(4):273-81. PubMed ID: 11202629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease].
    Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG
    Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

  • 40. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.